Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Podcasts

Matthew Robbins, MD: The State of Headache Medicine During COVID-19
Podcasts
Matthew Robbins, MD: The State of Headache Medicine During COVID-19
09/10/2020
In this podcast, Dr. Robbins discusses how the pandemic has impacted headache medicine, key areas of future research, and what neurologists should keep in mind. He recently gave a talk about this topic at the American Headache Society Annual...
In this podcast, Dr. Robbins discusses how the pandemic has impacted headache medicine, key areas of future research, and what neurologists should keep in mind. He recently gave a talk about this topic at the American Headache Society Annual...
In this podcast, Dr. Robbins...
09/10/2020
Neurology
John Leddy, MD, on Returning to Exercise After Concussion
Podcasts
John Leddy, MD, on Returning to Exercise After Concussion
09/08/2020
He discusses important considerations for returning to exercise post-concussion, explains common pitfalls in the diagnosis and treatment of sports-related concussion, and addresses treating acute sports-related concussion via early testing...
He discusses important considerations for returning to exercise post-concussion, explains common pitfalls in the diagnosis and treatment of sports-related concussion, and addresses treating acute sports-related concussion via early testing...
He discusses important...
09/08/2020
Neurology
Leigh Charvet, PhD, & Tehila Eilam-Stock, PhD, on Early Markers of Cognitive Involvement in MS
Podcasts
Leigh Charvet, PhD, & Tehila Eilam-Stock, PhD, on Early Markers of Cognitive Involvement in MS
09/03/2020
In this podcast, Dr Charvet and Dr Eilam-Stock discuss the findings from their study, which provided evidence of early neuropsychological markers of cognitive involvement among patients with multiple sclerosis.
In this podcast, Dr Charvet and Dr Eilam-Stock discuss the findings from their study, which provided evidence of early neuropsychological markers of cognitive involvement among patients with multiple sclerosis.
In this podcast, Dr Charvet and...
09/03/2020
Neurology

Advertisement

Patricia K. Coyle, MD, on Fluid and Neurophysiological Biomarkers for the Early Diagnosis of Progression of RRMS to SPMS
Podcasts
Patricia K. Coyle, MD, on Fluid and Neurophysiological Biomarkers for the Early Diagnosis of Progression of RRMS to SPMS
08/26/2020
She discusses the current state of evidence on the role of fluid and neurophysiological biomarkers in the early diagnosis of progression of relapsing-remitting MS to secondary progressive MS, and more.
She discusses the current state of evidence on the role of fluid and neurophysiological biomarkers in the early diagnosis of progression of relapsing-remitting MS to secondary progressive MS, and more.
She discusses the current state...
08/26/2020
Neurology
ANA Investigates Biomarkers for Alzheimer Disease
Podcasts
ANA Investigates Biomarkers for Alzheimer Disease
08/19/2020
David Holtzman, MD, talks about the established biomarkers for Alzheimer disease, potential biomarkers being investigated, and how long it may take for these biomarker tests to make it to the bedside.
David Holtzman, MD, talks about the established biomarkers for Alzheimer disease, potential biomarkers being investigated, and how long it may take for these biomarker tests to make it to the bedside.
David Holtzman, MD, talks about...
08/19/2020
Neurology
Shumei Man, MD, PhD, on Shortening Door-to-Needle Times in Acute Ischemic Stroke
Podcasts
Shumei Man, MD, PhD, on Shortening Door-to-Needle Times in Acute Ischemic Stroke
08/11/2020
In this podcast, Dr Man discusses the findings from her recent study, which indicated that shorter thrombolytic door-to-needle times were associated with lower all-cause readmission and lower all-cause mortality at 1 year among Medicare...
In this podcast, Dr Man discusses the findings from her recent study, which indicated that shorter thrombolytic door-to-needle times were associated with lower all-cause readmission and lower all-cause mortality at 1 year among Medicare...
In this podcast, Dr Man...
08/11/2020
Neurology

Advertisement

Vincent Martin, MD, on Migraine Triggers
Podcasts
Vincent Martin, MD, on Migraine Triggers
08/10/2020
In this podcast, Vincent Martin, MD, from the University of Cincinnati, defines migraine triggers, discusses the pathophysiology of migraine triggers, and explains how to clinically manage migraine triggers.
In this podcast, Vincent Martin, MD, from the University of Cincinnati, defines migraine triggers, discusses the pathophysiology of migraine triggers, and explains how to clinically manage migraine triggers.
In this podcast, Vincent Martin,...
08/10/2020
Neurology
ANA Investigates Embolic Strokes of Undetermined Source
Podcasts
ANA Investigates Embolic Strokes of Undetermined Source
08/06/2020
Hooman Kamel, MD, talks about embolic strokes of undetermined source (ESUS), the current standard of care for diagnosing and treating ESUS, and the evolution of research around ESUS.
Hooman Kamel, MD, talks about embolic strokes of undetermined source (ESUS), the current standard of care for diagnosing and treating ESUS, and the evolution of research around ESUS.
Hooman Kamel, MD, talks about...
08/06/2020
Neurology
John DeLuca, PhD, on Cognitive Rehabilitation Tools for Relapsing-Remitting MS
Podcasts
John DeLuca, PhD, on Cognitive Rehabilitation Tools for Relapsing-Remitting MS
07/27/2020
In this podcast, Dr DeLuca discusses the clinical course and prognosis of cognitive impairment in relapsing-remitting multiple sclerosis, as well as cognitive rehabilitation tools that are currently available and on the horizon.
In this podcast, Dr DeLuca discusses the clinical course and prognosis of cognitive impairment in relapsing-remitting multiple sclerosis, as well as cognitive rehabilitation tools that are currently available and on the horizon.
In this podcast, Dr DeLuca...
07/27/2020
Neurology

Advertisement

Justin McArthur, MBBS, MPH, on Addressing the “Uncomfortable Truths” in Health Care Disparities
Podcasts
Justin McArthur, MBBS, MPH, on Addressing the “Uncomfortable Truths” in Health Care Disparities
07/23/2020
He discusses the changes that need to be made in the research community to encompass a larger representative cohort, how current events will shape the future of neurology, and how the American Neurological Association has responded.
He discusses the changes that need to be made in the research community to encompass a larger representative cohort, how current events will shape the future of neurology, and how the American Neurological Association has responded.
He discusses the changes that...
07/23/2020
Neurology

Advertisement

Advertisement

News

an illustration of a brain against a black background, with a red area representing stroke.
News
Tenecteplase Suitable for Patients With Acute Ischemic Stroke
09/19/2024
In patients with acute ischemic stroke eligible for intravenous thrombolysis within 4.5 hours of symptom onset, tenecteplase was noninferior to alteplase for achieving an excellent functional outcome at day 90.
In patients with acute ischemic stroke eligible for intravenous thrombolysis within 4.5 hours of symptom onset, tenecteplase was noninferior to alteplase for achieving an excellent functional outcome at day 90.
In patients with acute ischemic...
09/19/2024
Neurology
a patient sits in a wheelchair
News
Phase 3 Studies Find Mixed Results for Investigational MS Drug
09/18/2024
An investigational drug for patients with multiple sclerosis (MS) yielded mixed results in a trio of phase 3 trials.
An investigational drug for patients with multiple sclerosis (MS) yielded mixed results in a trio of phase 3 trials.
An investigational drug for...
09/18/2024
Neurology
A woman holds her forehead in pain with a migraine
News
Single-Dose Infusion Reduces Migraine Frequency in Phase 2 Trial
09/13/2024
Intravenous Lu AG09222 reduced migraine frequency over 4 weeks in patients who had failed to find relief with previous treatments, according to a phase 2 trial published in the New England Journal of Medicine.
Intravenous Lu AG09222 reduced migraine frequency over 4 weeks in patients who had failed to find relief with previous treatments, according to a phase 2 trial published in the New England Journal of Medicine.
Intravenous Lu AG09222 reduced...
09/13/2024
Neurology
a scientist works with biomarkers in a lab
News
DYNE-251 for DMD Yields Promising Biomarker, Functional Results in Early-Stage Trial
09/10/2024
Patients with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping demonstrated unprecedented dystrophin expression and functional improvement with the investigational therapeutic DYNE-251.
Patients with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping demonstrated unprecedented dystrophin expression and functional improvement with the investigational therapeutic DYNE-251.
Patients with Duchenne muscular...
09/10/2024
Neurology
An elderly woman sits on a couch
News
Increasing Depression Symptoms in Older Adults Associated With Amyloid Accumulation
09/09/2024
Increasing depression symptoms in older adults were associated with early amyloid accumulation in regions responsible for emotional control, and may foretell later Alzheimer Disease (AD) development
Increasing depression symptoms in older adults were associated with early amyloid accumulation in regions responsible for emotional control, and may foretell later Alzheimer Disease (AD) development
Increasing depression symptoms...
09/09/2024
Psych Congress Network
Elderly Patient With Doctor
News
Patients with Multiple Sclerosis Less Likely to Develop Alzheimer Disease
09/03/2024
Patients with MS had about half the rate of amyloid pathology compared with matched control subjects in the Washington University School of Medicine study.
Patients with MS had about half the rate of amyloid pathology compared with matched control subjects in the Washington University School of Medicine study.
Patients with MS had about half...
09/03/2024
Neurology
an older adult lies in a hospital bed with head turned looking out of a window
News
Suvorexant Associated With Lower Delirium Rates in Some Hospitalized Older Adults
08/29/2024
Suvorexant, a sleep-promoting orexin receptor antagonist, was associated with lower rates of delirium than placebo in hospitalized older adults at high risk of delirium, but the difference was not statistically significant.
Suvorexant, a sleep-promoting orexin receptor antagonist, was associated with lower rates of delirium than placebo in hospitalized older adults at high risk of delirium, but the difference was not statistically significant.
Suvorexant, a sleep-promoting...
08/29/2024
Psych Congress Network
A woman holds her forehead in pain with a migraine
News
No Link Found Between Migraine and Parkinson Disease, Contrary to Previous Findings
08/28/2024
A new cohort study involving female participants found no link between migraine and later Parkinson disease (PD) development. Findings from the study were published in Neurology.
A new cohort study involving female participants found no link between migraine and later Parkinson disease (PD) development. Findings from the study were published in Neurology.
A new cohort study involving...
08/28/2024
Neurology
a young boy sits and works at a desk in a classroom
News
Back-to-School Season Overshadowed By Ongoing Stimulant Med Shortages
08/27/2024
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
As millions of Americans, both...
08/27/2024
Psych Congress Network
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use